I've been on the sidelines for a while now. listening. reading. All relatively good points on both sides.
My take..
For every share sold there is a buyer.. funny how at the beginning of the day the buyers volume never equates to the total shares sold..! If the amount of shares sold today happened in one dump our price would be 4c, give or take..
There is a sell off happening no doubt. but smart money is changing hands from the left hand to the right hand.
There are much bigger boys in play than anyone posting here on hot copper. We are just along for the ride in hope to make a buck but for the most part will just get caught up in the collateral damage of THE SYSTEM..
For any start up to be successful they need funding. A damn good product (SFG) helps. but for most other specs they really need to sleep and make deals with the devil. I believe this is the tedious task SAS is undertaking at the moment.
Our directors assured they will keep their shares in escrow unless to benefit the company by selling them. This in my opinion is how they will kick things off.
They want the share price to come down enough for a deal to look appealing enough, then I believe they will split with 30% of each directors share.. at 4.5c x 300m shares = $13.5 mill (forgive a few million shares or a fee cents run with the concept)
This coupled with a handsome grant from the emerging Australian space agency you'll see more than enough funding to get the first batch of pearls up..
Share price will shoot to +20c with released escrow shares included will give a market cap of $400mill which should become our support .. if course once this occurs we will see a 5:1 consolidation I believe needs to happen to stop the complete dumping and manipulation of this stock..
Food for thought..
- Forums
- ASX - By Stock
- SAS
- 4 cents sas ?
4 cents sas ?, page-24
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SAS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online